Revolution Medicines gets FDA nod for targeted pancreatic cancer drug
Pancreatic cancer has long been regarded as one of the most lethal malignancies in modern oncology, with a five-year survival rate hovering…
Taste the storyCategory: Health
People are exercising away their grief. What does the science say?
In a dimly lit New York gym, thirty people stood in silence, tears streaming down their faces before a single rep had…
Taste the story
Two people in Pennsylvania have died from measles
The state of Pennsylvania confirmed on Tuesday that two residents have died from measles, marking the first fatalities from the disease in…
Taste the story
Roche, Eli Lilly’s Alzheimer’s blood test gets FDA clearance
For decades, confirming whether a patient's memory lapses stem from Alzheimer's disease required either a costly brain scan or a needle through…
Taste the story
‘Loneliness influencers’ have no friends, but they say they’re happy. What they can teach us
The World Health Organization now classifies loneliness as a global health priority, and roughly one in four adults says they feel lonely.…
Taste the story
Maternal mental health is making headlines. Experts say it’s long overdue
The summer of 2026 brought an unlikely convergence of events that thrust maternal mental health from whispered conversations into the national spotlight.…
Taste the story
‘Cancer has taken so much … but it’s also given us a few things’: One family’s journey
For the McMahon family of Portland, Oregon, the word "normal" has taken on a very different meaning over the past half-decade. What…
Taste the story
You want to join a clinical trial. Here’s what to know about the hurdles.
A recent online survey polling more than 2,000 adults revealed a striking disconnect in American healthcare: 71% of respondents living with chronic…
Taste the story
Trump expected to pick Dr. Heidi Overton to lead FDA
Dr. Heidi Overton is poised to become the next commissioner of the US Food and Drug Administration, a move that would place…
Taste the story
How much of a cancer drug is too much? Patients, researchers challenge FDA-approved dosages
How much of a cancer drug does a patient truly need before the label's default dose becomes more burden than benefit? That…
Taste the story